Advances in inflammatory bowel disease (IBD) treatment have improved outcomes for many patients but personalizing therapy and predicting response to therapy is a huge challenge. This has led to underutilization of effective regimens, undertreatment, and suboptimal outcomes. This activity reviews how new and emerging clinical decision support tools can help providers bridge this gap by predicting individualized disease complication risk and response to therapy.
Upon successful completion of this educational activity, participants should be better able to:
Assistant Professor
UC San Diego School of Medicine
San Diego, CA
Assistant Clinical Professor
UC San Diego School of Medicine
San Diego, CA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources